|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 335 for Il1rl1

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.035s

Categories

Category: Publication
Type Details Score
Publication
First Author: Kikuchi M
Year: 2020
Journal: Mol Brain
Title: Altered behavior in mice overexpressing soluble ST2.
Volume: 13
Issue: 1
Pages: 74
Publication
First Author: Ohto-Ozaki H
Year: 2010
Journal: Eur J Immunol
Title: Characterization of ST2 transgenic mice with resistance to IL-33.
Volume: 40
Issue: 9
Pages: 2632-42
Publication
First Author: Senn KA
Year: 2000
Journal: Eur J Immunol
Title: T1-deficient and T1-Fc-transgenic mice develop a normal protective Th2-type immune response following infection with Nippostrongylus brasiliensis.
Volume: 30
Issue: 7
Pages: 1929-38
Publication
First Author: Nabekura T
Year: 2015
Journal: J Immunol
Title: IL-33 receptor ST2 amplifies the expansion of NK cells and enhances host defense during mouse cytomegalovirus infection.
Volume: 194
Issue: 12
Pages: 5948-52
Publication
First Author: Sun R
Year: 2023
Journal: Sci Adv
Title: Amphiregulin couples IL1RL1(+) regulatory T cells and cancer-associated fibroblasts to impede antitumor immunity.
Volume: 9
Issue: 34
Pages: eadd7399
Publication
First Author: Wang L
Year: 2020
Journal: Nat Commun
Title: TGF-β induces ST2 and programs ILC2 development.
Volume: 11
Issue: 1
Pages: 35
Publication
First Author: Griesenauer B
Year: 2019
Journal: J Immunol
Title: ST2/MyD88 Deficiency Protects Mice against Acute Graft-versus-Host Disease and Spares Regulatory T Cells.
Volume: 202
Issue: 10
Pages: 3053-3064
Publication  
First Author: Zarnegar B
Year: 2018
Journal: Front Immunol
Title: Innate Immunity Induces the Accumulation of Lung Mast Cells During Influenza Infection.
Volume: 9
Pages: 2288
Publication
First Author: Tominaga S
Year: 1989
Journal: FEBS Lett
Title: A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor.
Volume: 258
Issue: 2
Pages: 301-4
Publication
First Author: Klemenz R
Year: 1989
Journal: Proc Natl Acad Sci U S A
Title: Serum- and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen.
Volume: 86
Issue: 15
Pages: 5708-12
Publication
First Author: Townsend MJ
Year: 2000
Journal: J Exp Med
Title: T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses.
Volume: 191
Issue: 6
Pages: 1069-76
Publication  
First Author: Zhao J
Year: 2013
Journal: Neuroscience
Title: Spinal interleukin-33 and its receptor ST2 contribute to bone cancer-induced pain in mice.
Volume: 253
Pages: 172-82
Publication
First Author: Chhiba KD
Year: 2017
Journal: J Immunol
Title: Transcriptional Heterogeneity of Mast Cells and Basophils upon Activation.
Volume: 198
Issue: 12
Pages: 4868-4878
Publication  
First Author: Fanny M
Year: 2018
Journal: Front Immunol
Title: The IL-33 Receptor ST2 Regulates Pulmonary Inflammation and Fibrosis to Bleomycin.
Volume: 9
Pages: 1476
Publication
First Author: Ajendra J
Year: 2014
Journal: PLoS One
Title: ST2 deficiency does not impair type 2 immune responses during chronic filarial infection but leads to an increased microfilaremia due to an impaired splenic microfilarial clearance.
Volume: 9
Issue: 3
Pages: e93072
Publication
First Author: Milovanovic M
Year: 2012
Journal: PLoS One
Title: Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotype.
Volume: 7
Issue: 9
Pages: e45225
Publication
First Author: Buckley JM
Year: 2011
Journal: J Immunol
Title: Increased susceptibility of ST2-deficient mice to polymicrobial sepsis is associated with an impaired bactericidal function.
Volume: 187
Issue: 8
Pages: 4293-9
Publication
First Author: Brint EK
Year: 2004
Journal: Nat Immunol
Title: ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance.
Volume: 5
Issue: 4
Pages: 373-9
Publication
First Author: Blok DC
Year: 2013
Journal: PLoS One
Title: Limited anti-inflammatory role for interleukin-1 receptor like 1 (ST2) in the host response to murine postinfluenza pneumococcal pneumonia.
Volume: 8
Issue: 3
Pages: e58191
Publication
First Author: Zdravkovic N
Year: 2009
Journal: Mol Immunol
Title: Regulatory T cells and ST2 signaling control diabetes induction with multiple low doses of streptozotocin.
Volume: 47
Issue: 1
Pages: 28-36
Publication  
First Author: Schaunaman N
Year: 2019
Journal: Infect Immun
Title: Interleukin 1 Receptor-Like 1 (IL1RL1) Promotes Airway Bacterial and Viral Infection and Inflammation.
Volume: 87
Issue: 7
Publication
First Author: Coakley G
Year: 2017
Journal: Cell Rep
Title: Extracellular Vesicles from a Helminth Parasite Suppress Macrophage Activation and Constitute an Effective Vaccine for Protective Immunity.
Volume: 19
Issue: 8
Pages: 1545-1557
Publication
First Author: Mangan NE
Year: 2007
Journal: Eur J Immunol
Title: T1/ST2 expression on Th2 cells negatively regulates allergic pulmonary inflammation.
Volume: 37
Issue: 5
Pages: 1302-12
Publication
First Author: Jovanovic I
Year: 2011
Journal: Eur J Immunol
Title: ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma.
Volume: 41
Issue: 7
Pages: 1902-12
Publication
First Author: McLaren JE
Year: 2010
Journal: J Immunol
Title: IL-33 reduces macrophage foam cell formation.
Volume: 185
Issue: 2
Pages: 1222-9
Publication
First Author: Jin Z
Year: 2018
Journal: J Immunol
Title: IL-33 Released in the Liver Inhibits Tumor Growth via Promotion of CD4+ and CD8+ T Cell Responses in Hepatocellular Carcinoma.
Volume: 201
Issue: 12
Pages: 3770-3779
Publication
First Author: Mertz KD
Year: 2016
Journal: Oncoimmunology
Title: The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice.
Volume: 5
Issue: 1
Pages: e1062966
Publication
First Author: Mirchandani AS
Year: 2014
Journal: J Immunol
Title: Type 2 innate lymphoid cells drive CD4+ Th2 cell responses.
Volume: 192
Issue: 5
Pages: 2442-8
Publication  
First Author: Topczewska PM
Year: 2023
Journal: Front Immunol
Title: ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses.
Volume: 14
Pages: 1130933
Publication
First Author: Kasahara DI
Year: 2019
Journal: Respir Res
Title: The interleukin-33 receptor contributes to pulmonary responses to ozone in male mice: role of the microbiome.
Volume: 20
Issue: 1
Pages: 197
Publication
First Author: Barbour M
Year: 2014
Journal: Eur J Immunol
Title: IL-33 attenuates the development of experimental autoimmune uveitis.
Volume: 44
Issue: 11
Pages: 3320-9
Publication  
First Author: Xie D
Year: 2022
Journal: Front Immunol
Title: IL-33/ST2 Axis Protects Against Traumatic Brain Injury Through Enhancing the Function of Regulatory T Cells.
Volume: 13
Pages: 860772
Publication  
First Author: Viana CTR
Year: 2022
Journal: Microvasc Res
Title: ST2 deletion accelerates inflammatory-angiogenesis and remodeling in subcutaneous implants in mice.
Volume: 139
Pages: 104277
Publication
First Author: Palomo J
Year: 2015
Journal: Eur J Immunol
Title: Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.
Volume: 45
Issue: 5
Pages: 1354-65
Publication
First Author: Savinko T
Year: 2013
Journal: J Invest Dermatol
Title: ST2 regulates allergic airway inflammation and T-cell polarization in epicutaneously sensitized mice.
Volume: 133
Issue: 11
Pages: 2522-2529
Publication
First Author: Hoshino K
Year: 1999
Journal: J Exp Med
Title: The absence of interleukin 1 receptor-related T1/ST2 does not affect T helper cell type 2 development and its effector function.
Volume: 190
Issue: 10
Pages: 1541-8
Publication  
First Author: Okamura T
Year: 2021
Journal: Front Immunol
Title: ILC2s Improve Glucose Metabolism Through the Control of Saturated Fatty Acid Absorption Within Visceral Fat.
Volume: 12
Pages: 669629
Publication
First Author: Zhao Y
Year: 2018
Journal: J Pathol
Title: An ST2-dependent role of bone marrow-derived group 2 innate lymphoid cells in pulmonary fibrosis.
Volume: 245
Issue: 4
Pages: 399-409
Publication
First Author: Rössler U
Year: 1995
Journal: Dev Biol
Title: Secreted and membrane-bound isoforms of T1, an orphan receptor related to IL-1-binding proteins, are differently expressed in vivo.
Volume: 168
Issue: 1
Pages: 86-97
Publication
First Author: Yanagisawa K
Year: 1992
Journal: FEBS Lett
Title: Murine ST2 gene is a member of the primary response gene family induced by growth factors.
Volume: 302
Issue: 1
Pages: 51-3
Publication
First Author: Takagi T
Year: 1993
Journal: Biochim Biophys Acta
Title: Identification of the product of the murine ST2 gene.
Volume: 1178
Issue: 2
Pages: 194-200
Publication
First Author: Trüb T
Year: 1994
Journal: Proc Natl Acad Sci U S A
Title: Growth factor-mediated induction of the delayed early gene T1 depends on a 12-O-tetradecanoylphorbol 13-acetate-responsive element located 3.6 kb upstream of the transcription initiation site.
Volume: 91
Issue: 9
Pages: 3896-900
Publication
First Author: Schuchardt A
Year: 1995
Journal: Oncogene
Title: Isolation and characterization of a chicken homolog of the c-ret proto-oncogene.
Volume: 10
Issue: 4
Pages: 641-9
Publication
First Author: Tominaga S
Year: 1996
Journal: Hum Genet
Title: Assignment of the human ST2 gene to chromosome 2 at q11.2.
Volume: 97
Issue: 5
Pages: 561-3
Publication
First Author: Löhning M
Year: 1998
Journal: Proc Natl Acad Sci U S A
Title: T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function.
Volume: 95
Issue: 12
Pages: 6930-5
Publication
First Author: Liu J
Year: 2010
Journal: J Immunol
Title: ST2 negatively regulates TLR2 signaling, but is not required for bacterial lipoprotein-induced tolerance.
Volume: 184
Issue: 10
Pages: 5802-8
Publication
First Author: Ramaprakash H
Year: 2011
Journal: Am J Pathol
Title: Targeting ST2L potentiates CpG-mediated therapeutic effects in a chronic fungal asthma model.
Volume: 179
Issue: 1
Pages: 104-15
Publication
First Author: Tsuzuki H
Year: 2017
Journal: Immunology
Title: Functional interleukin-33 receptors are expressed in early progenitor stages of allergy-related granulocytes.
Volume: 150
Issue: 1
Pages: 64-73
Publication
First Author: Franca RF
Year: 2016
Journal: J Neuroinflammation
Title: IL-33 signaling is essential to attenuate viral-induced encephalitis development by downregulating iNOS expression in the central nervous system.
Volume: 13
Issue: 1
Pages: 159
Publication
First Author: Lee JS
Year: 2016
Journal: Exp Dermatol
Title: ST2 receptor invalidation maintains wound inflammation, delays healing and increases fibrosis.
Volume: 25
Issue: 1
Pages: 71-4
Publication  
First Author: Stankovic MS
Year: 2022
Journal: Exp Mol Pathol
Title: ST2 and the alteration of cobalt, sodium, potassium and calcium concentration in acute inflammation.
Volume: 128
Pages: 104820
Publication
First Author: Bergers G
Year: 1994
Journal: EMBO J
Title: Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor.
Volume: 13
Issue: 5
Pages: 1176-88
Publication
First Author: Wen T
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Eosinophil adoptive transfer system to directly evaluate pulmonary eosinophil trafficking in vivo.
Volume: 110
Issue: 15
Pages: 6067-72
Publication  
First Author: Ryffel B
Year: 2019
Journal: Front Immunol
Title: Blockade of IL-33R/ST2 Signaling Attenuates Toxoplasma gondii Ileitis Depending on IL-22 Expression.
Volume: 10
Pages: 702
Publication
First Author: Cohen M
Year: 2018
Journal: Cell
Title: Lung Single-Cell Signaling Interaction Map Reveals Basophil Role in Macrophage Imprinting.
Volume: 175
Issue: 4
Pages: 1031-1044.e18
Publication      
First Author: Brandt EB
Year: 2023
Journal: J Allergy Clin Immunol
Title: Thymic stromal lymphopoietin rather than IL-33 drives food allergy after epicutaneous sensitization to food allergen.
Publication  
First Author: Maes B
Year: 2023
Journal: J Exp Med
Title: STE20 kinase TAOK3 regulates type 2 immunity and metabolism in obesity.
Volume: 220
Issue: 9
Publication
First Author: Yanagisawa K
Year: 1993
Journal: FEBS Lett
Title: Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1.
Volume: 318
Issue: 1
Pages: 83-7
Publication
First Author: Schmitz J
Year: 2005
Journal: Immunity
Title: IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.
Volume: 23
Issue: 5
Pages: 479-90
Publication
First Author: Hueber AJ
Year: 2011
Journal: Eur J Immunol
Title: IL-33 induces skin inflammation with mast cell and neutrophil activation.
Volume: 41
Issue: 8
Pages: 2229-37
Publication
First Author: Xu D
Year: 2010
Journal: J Immunol
Title: IL-33 exacerbates autoantibody-induced arthritis.
Volume: 184
Issue: 5
Pages: 2620-6
Publication  
First Author: Staurengo-Ferrari L
Year: 2018
Journal: Front Immunol
Title: Interleukin-33 Receptor (ST2) Deficiency Improves the Outcome of Staphylococcus aureus-Induced Septic Arthritis.
Volume: 9
Pages: 962
Publication
First Author: Garth JM
Year: 2017
Journal: J Immunol
Title: IL-33 Signaling Regulates Innate IL-17A and IL-22 Production via Suppression of Prostaglandin E2 during Lung Fungal Infection.
Volume: 199
Issue: 6
Pages: 2140-2148
Publication
First Author: Ferhat M
Year: 2018
Journal: J Am Soc Nephrol
Title: Endogenous IL-33 Contributes to Kidney Ischemia-Reperfusion Injury as an Alarmin.
Volume: 29
Issue: 4
Pages: 1272-1288
Publication  
First Author: Han P
Year: 2013
Journal: Neuroscience
Title: Interleukin-33 mediates formalin-induced inflammatory pain in mice.
Volume: 241
Pages: 59-66
Publication
First Author: Pietka W
Year: 2020
Journal: Sci Rep
Title: Lack of interleukin-33 and its receptor does not prevent calcipotriol-induced atopic dermatitis-like inflammation in mice.
Volume: 10
Issue: 1
Pages: 6451
Publication
First Author: Tan Z
Year: 2018
Journal: Cell Mol Immunol
Title: Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells.
Volume: 15
Issue: 4
Pages: 388-398
Publication
First Author: Luzina IG
Year: 2013
Journal: Am J Respir Cell Mol Biol
Title: Interleukin-33 potentiates bleomycin-induced lung injury.
Volume: 49
Issue: 6
Pages: 999-1008
Publication
First Author: Yu XX
Year: 2008
Journal: Am J Physiol Endocrinol Metab
Title: Reduction of JNK1 expression with antisense oligonucleotide improves adiposity in obese mice.
Volume: 295
Issue: 2
Pages: E436-45
Publication
First Author: Marques RE
Year: 2018
Journal: Immunology
Title: Interleukin-33 contributes to disease severity in Dengue virus infection in mice.
Volume: 155
Issue: 4
Pages: 477-490
Publication
First Author: Kasahara DI
Year: 2020
Journal: Respir Res
Title: IL-33, diet-induced obesity, and pulmonary responses to ozone.
Volume: 21
Issue: 1
Pages: 98
Publication
First Author: Li D
Year: 2014
Journal: J Allergy Clin Immunol
Title: IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice.
Volume: 134
Issue: 6
Pages: 1422-1432.e11
Publication
First Author: Stier MT
Year: 2018
Journal: J Exp Med
Title: IL-33 promotes the egress of group 2 innate lymphoid cells from the bone marrow.
Volume: 215
Issue: 1
Pages: 263-281
Publication
First Author: Hsu CL
Year: 2010
Journal: PLoS One
Title: IL-33 is produced by mast cells and regulates IgE-dependent inflammation.
Volume: 5
Issue: 8
Pages: e11944
Publication  
First Author: Hussey GS
Year: 2019
Journal: J Immunol Regen Med
Title: Matrix bound nanovesicle-associated IL-33 activates a pro-remodeling macrophage phenotype via a non-canonical, ST2-independent pathway.
Volume: 3
Pages: 26-35
Publication
First Author: Reverchon F
Year: 2017
Journal: PLoS Pathog
Title: IL-33 receptor ST2 regulates the cognitive impairments associated with experimental cerebral malaria.
Volume: 13
Issue: 4
Pages: e1006322
Publication
First Author: Endo Y
Year: 2015
Journal: Immunity
Title: The interleukin-33-p38 kinase axis confers memory T helper 2 cell pathogenicity in the airway.
Volume: 42
Issue: 2
Pages: 294-308
Publication
First Author: O'Grady K
Year: 2019
Journal: J Immunol
Title: IL-33 Is a Negative Regulator of Vaccine-Induced Antigen-Specific Cellular Immunity.
Volume: 202
Issue: 4
Pages: 1145-1152
Publication
First Author: Rostan O
Year: 2013
Journal: mBio
Title: The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani.
Volume: 4
Issue: 5
Pages: e00383-13
Publication
First Author: Sanada S
Year: 2007
Journal: J Clin Invest
Title: IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.
Volume: 117
Issue: 6
Pages: 1538-49
Publication
First Author: Theodoropoulou S
Year: 2017
Journal: J Pathol
Title: Interleukin-33 regulates tissue remodelling and inhibits angiogenesis in the eye.
Volume: 241
Issue: 1
Pages: 45-56
Publication
First Author: Jiang HR
Year: 2012
Journal: Eur J Immunol
Title: IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages.
Volume: 42
Issue: 7
Pages: 1804-14
Publication
First Author: Zarpelon AC
Year: 2016
Journal: FASEB J
Title: Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain.
Volume: 30
Issue: 1
Pages: 54-65
Publication
First Author: Martin P
Year: 2013
Journal: Arthritis Res Ther
Title: Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency.
Volume: 15
Issue: 1
Pages: R13
Publication
First Author: Li J
Year: 2019
Journal: Arterioscler Thromb Vasc Biol
Title: IL (Interleukin)-33 Suppresses Abdominal Aortic Aneurysm by Enhancing Regulatory T-Cell Expansion and Activity.
Volume: 39
Issue: 3
Pages: 446-458
Publication
First Author: Frisbee AL
Year: 2019
Journal: Nat Commun
Title: IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection.
Volume: 10
Issue: 1
Pages: 2712
Publication  
First Author: Luzina IG
Year: 2019
Journal: Cytokine
Title: Identification of the IL-33 protein segment that controls subcellular localization, extracellular secretion, and functional maturation.
Volume: 119
Pages: 1-6
Publication
First Author: Popovic B
Year: 2017
Journal: PLoS Pathog
Title: IL-33/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infection.
Volume: 13
Issue: 4
Pages: e1006345
Publication
First Author: Fu AK
Year: 2016
Journal: Proc Natl Acad Sci U S A
Title: IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline.
Volume: 113
Issue: 19
Pages: E2705-13
Publication
First Author: Kearley J
Year: 2015
Journal: Immunity
Title: Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection.
Volume: 42
Issue: 3
Pages: 566-79
Publication  
First Author: Mahlakõiv T
Year: 2019
Journal: Sci Immunol
Title: Stromal cells maintain immune cell homeostasis in adipose tissue via production of interleukin-33.
Volume: 4
Issue: 35
Publication
First Author: Lopetuso LR
Year: 2018
Journal: Proc Natl Acad Sci U S A
Title: IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair.
Volume: 115
Issue: 40
Pages: E9362-E9370
Publication
First Author: Ouziel R
Year: 2012
Journal: Am J Pathol
Title: The ST2 pathway is involved in acute pancreatitis: a translational study in humans and mice.
Volume: 180
Issue: 6
Pages: 2330-9
Publication
First Author: Guo L
Year: 2015
Journal: Nat Immunol
Title: Innate immunological function of TH2 cells in vivo.
Volume: 16
Issue: 10
Pages: 1051-9
Publication
First Author: Xi H
Year: 2016
Journal: J Exp Med
Title: IL-33 amplifies an innate immune response in the degenerating retina.
Volume: 213
Issue: 2
Pages: 189-207
Publication  
First Author: Jackson-Jones LH
Year: 2016
Journal: Nat Commun
Title: Fat-associated lymphoid clusters control local IgM secretion during pleural infection and lung inflammation.
Volume: 7
Pages: 12651
Publication
First Author: Saravia J
Year: 2015
Journal: PLoS Pathog
Title: Respiratory Syncytial Virus Disease Is Mediated by Age-Variable IL-33.
Volume: 11
Issue: 10
Pages: e1005217
Publication  
First Author: Garbern JC
Year: 2019
Journal: J Mol Cell Cardiol
Title: Dysregulation of IL-33/ST2 signaling and myocardial periarteriolar fibrosis.
Volume: 128
Pages: 179-186
Publication
First Author: Besnard AG
Year: 2011
Journal: Eur J Immunol
Title: IL-33-activated dendritic cells are critical for allergic airway inflammation.
Volume: 41
Issue: 6
Pages: 1675-86
Publication      
First Author: Cheon SY
Year: 2022
Journal: J Invest Dermatol
Title: IL-33/Regulatory T-Cell Axis Suppresses Skin Fibrosis.